PT523 Self-Care, Destabilization, and the Holistic Nature of Psychedelics, with Kaitlin Roberson & Dr. Michele Cox, DO

Published: June 21, 2024, 2:20 p.m.

In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel therapies for chronic pain; and Dr. Michele Cox, DO: current Vital student, veteran, physician, and co-founder of LifeBloom, a brand new company focusing on bringing community and connection into women\u2019s healthcare.

They talk about their work: Roberson\u2019s research on trauma and chronic pain, and why she feels that working in the pharma industry is a calling; and Cox\u2019s framework as an osteopath, the value she\u2019s found in touch and connection, and how she explains to clients what to expect when undergoing ketamine treatment.

They discuss:

  • Why psychedelics are such useful interventions
  • The body\u2019s ability to tell us what\u2019s wrong, as long we\u2019re listening
  • The destabilization that can occur after a big experience: If you don\u2019t have a good support system, is it really the right time?
  • Self-care and our tendency to never feel like we\u2019re good enough
  • How there is energy in everything and we should all recognize that more

And, as Vital students, they talk about what they hoped to get out of Vital and how it delivered more than expected. If you\u2019re just discovering Vital, be sure to check out the website and fill out an application. Secure your spot and take advantage of the Early Bird discount!

For links, head to teh show notes page.\xa0